Clinical Efficacy of Ambroxol Combined with Budesonide Nebulized Inhalation in the Treatment of Neonatal Pneumonia
Objective Study on the clinical effect of ambroxol combined with budesonide nebulized inhalation in the treatment of neonatal pneumonia.Methods Selecting 60 newborns with pneumonia admitted to our hospital from June 2018 to June 2023 as the research subjects,divide them into a control group and an experimental group using a random number table method,with 30 cases in each group.The control group was given budesonide atomization nebulized inhalation treatment,and the experimental group was given ambroxol combined with budesonide nebulized inhalation treatment.The clinical efficacy,conversion rate of chest imaging,levels of inflammatory factor indicators,and occurrence of adverse reactions were compared between the two groups.Results The total effective rate of the experimental group was higher than that of the control group,the differences was statistically significant(P＜0.05).The conversion rate of chest imaging in the experimental group was higher than that in the control group,the differences was statistically significant(P＜0.05).After treatment,the levels of C-reactive protein,interleukin-6,and white blood cell count in the experimental group were lower than those in the control group,the differences between groups were statistically significant(P＜0.05).Neither group experienced serious adverse reactions.Conclusion The combination of ambroxol and budesonide nebulized inhalation has a significant effect on the treatment of neonatal pneumonia,the chest imaging examination results of the patient have been improved,the inflammatory response has been alleviated,and the treatment safety is relatively high.
NETL
NSTL
万方数据
